Nuburu S-1: YA II PN to Resell 130M Shares; Company Eyes $28.5M from SEPA
Ticker: BURUW · Form: S-1 · Filed: Dec 12, 2025 · CIK: 1814215
Sentiment: bearish
Topics: Equity Offering, Dilution Risk, Emerging Growth Company, Laser Technology, Standby Equity Purchase Agreement, NYSE American, S-1 Filing
Related Tickers: BURU
TL;DR
**Nuburu's S-1 is a red flag, signaling massive dilution potential from YA II PN's resale of 130 million shares and the company's own $28.5 million equity facility, making it a speculative bet at best.**
AI Summary
Nuburu, Inc. (BURUW) is not selling any securities under this S-1 filing and will not receive any proceeds from the sale of up to 130 million shares of common stock by the Selling Stockholder, YA II PN, LTD. However, Nuburu may receive up to $28.5 million in aggregate gross proceeds from sales of Common Stock it may elect to make to the Selling Stockholder pursuant to the Standby Equity Purchase Agreement (SEPA) dated May 30, 2025. The last quoted sale price for Nuburu's Common Stock on the NYSE American was $0.2262 per share as of December 8, 2025. The company is an 'emerging growth company' and its common stock is traded under the symbol 'BURU'. A key business change involves the potential for future acquisitions, partnerships, or other relationships with third parties, as well as diversifying assets and expanding international operations, including potential deals with Lyocon S.r.l., Orbit S.r.l., and Tekne S.p.A. A significant risk highlighted is the company's inability to achieve commercialization, despite its plans for product development and pipeline. The strategic outlook includes obtaining required financing and maintaining its NYSE American listing.
Why It Matters
This S-1 filing signals a significant liquidity event for YA II PN, LTD., which could introduce substantial selling pressure on Nuburu's stock, currently trading at $0.2262 per share. For investors, the potential for up to 130 million shares to hit the market, coupled with Nuburu's own potential sales of up to $28.5 million to the Selling Stockholder, creates considerable uncertainty regarding future share price stability. Employees and customers should monitor the company's ability to secure additional financing and achieve commercialization, as these factors are critical for long-term operational viability and product delivery in the competitive laser technology market. The broader market will watch how Nuburu navigates its 'emerging growth company' status and its stated intent to diversify assets and expand internationally, particularly given its current lack of commercialization.
Risk Assessment
Risk Level: high — The risk level is high due to the potential resale of up to 130 million shares by YA II PN, LTD., which could significantly dilute existing shareholders and depress the stock price, especially given the current price of $0.2262 per share as of December 8, 2025. Furthermore, Nuburu explicitly states it 'has not achieved commercialization' and its ability to do so in the future is a key uncertainty, indicating a lack of stable revenue generation.
Analyst Insight
Investors should exercise extreme caution and consider avoiding BURUW given the substantial dilution risk from the 130 million share resale and the company's unproven commercialization. Current shareholders should evaluate their position, as significant selling pressure could drive the stock price lower from its current $0.2262 per share.
Financial Highlights
- debt To Equity
- N/A
- revenue
- N/A
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- N/A
- eps
- N/A
- gross Margin
- N/A
- cash Position
- N/A
- revenue Growth
- N/A
Key Numbers
- 130 million — Shares of Common Stock (Maximum shares offered for resale by YA II PN, LTD.)
- $28.5 million — Potential Gross Proceeds (Maximum proceeds Nuburu may receive from sales to YA II PN, LTD. via SEPA)
- $0.2262 — Share Price (Closing sale price of BURU on NYSE American as of December 8, 2025)
- May 30, 2025 — SEPA Date (Date of the Standby Equity Purchase Agreement with YA II PN, LTD.)
- December 12, 2025 — Filing Date (Date the S-1 registration statement was filed)
Key Players & Entities
- Nuburu, Inc. (company) — Registrant and issuer of common stock
- YA II PN, LTD. (company) — Selling Stockholder of up to 130 million shares
- Alessandro Zamboni (person) — Executive Chairman of Nuburu, Inc.
- Amy Bowler (person) — Legal counsel from Holland & Hart LLP
- SEC (regulator) — United States Securities and Exchange Commission
- $28.5 million (dollar_amount) — Aggregate gross proceeds Nuburu may receive from sales to Selling Stockholder
- $0.2262 (dollar_amount) — Last quoted sale price per share of Common Stock on December 8, 2025
- NYSE American (regulator) — Stock exchange where Nuburu's Common Stock is traded
- Lyocon S.r.l. (company) — Italian photonics and laser-engineering company, potential acquisition target
- Tekne S.p.A. (company) — Defense-tech company, potential acquisition target
FAQ
What is the purpose of Nuburu, Inc.'s S-1 filing on December 12, 2025?
The S-1 filing by Nuburu, Inc. on December 12, 2025, is for the resale of up to 130 million shares of common stock by the Selling Stockholder, YA II PN, LTD. Nuburu itself is not selling any securities under this prospectus and will not receive any proceeds from this specific resale.
How much money could Nuburu, Inc. potentially receive from the Standby Equity Purchase Agreement?
Nuburu, Inc. may receive up to $28.5 million in aggregate gross proceeds from sales of Common Stock it may elect to make to the Selling Stockholder, YA II PN, LTD., pursuant to the Standby Equity Purchase Agreement (SEPA) dated May 30, 2025.
What is the current trading price of Nuburu, Inc. common stock?
As of December 8, 2025, the last quoted sale price for Nuburu, Inc.'s Common Stock (BURU) on the NYSE American was $0.2262 per share.
Who is the Selling Stockholder in this Nuburu S-1 filing?
The Selling Stockholder in this Nuburu S-1 filing is YA II PN, LTD., which is offering to resell up to 130 million shares of Nuburu's common stock.
What are the main risks highlighted for investors in Nuburu, Inc.?
Key risks for investors in Nuburu, Inc. include the potential for significant dilution from the resale of up to 130 million shares by YA II PN, LTD., the company's explicit statement that it 'has not achieved commercialization,' and its need to obtain required financing and maintain its NYSE American listing.
Is Nuburu, Inc. considered an 'emerging growth company'?
Yes, Nuburu, Inc. is an 'emerging growth company' as defined in Section 2(a) of the Securities Act and is subject to reduced public company reporting requirements.
What are Nuburu, Inc.'s strategic plans for business expansion?
Nuburu, Inc.'s strategic plans include diversifying its assets, expanding with international operations, and pursuing future acquisitions, partnerships, or other relationships with third parties, specifically mentioning potential deals with Lyocon S.r.l., Orbit S.r.l., and Tekne S.p.A.
Will Nuburu, Inc. receive any proceeds from the 130 million share resale by YA II PN, LTD.?
No, Nuburu, Inc. will not receive any of the proceeds from the sale of its Common Stock by the Selling Stockholder, YA II PN, LTD., in this specific resale offering.
Who is Alessandro Zamboni and what is his role at Nuburu, Inc.?
Alessandro Zamboni is the Executive Chairman of Nuburu, Inc. and is also associated with Vanguard Holdings S.r.l., an Italian limited liability company wholly owned by him.
What is the significance of the Standby Equity Purchase Agreement for Nuburu, Inc.?
The Standby Equity Purchase Agreement (SEPA) allows Nuburu, Inc. to elect to sell Common Stock to YA II PN, LTD., potentially generating up to $28.5 million in gross proceeds for the company, which is crucial for its operations and future plans given its current lack of commercialization.
Risk Factors
- Reliance on Standby Equity Purchase Agreement [high — financial]: The company's ability to raise capital is significantly dependent on the Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. This agreement allows Nuburu to sell up to $28.5 million in aggregate gross proceeds of common stock to YA II PN, LTD. The effectiveness of this agreement is crucial for future operations and potential growth initiatives.
- Commercialization Challenges [high — operational]: A significant risk highlighted is the company's inability to achieve commercialization of its products. Despite plans for product development and a pipeline, there is no assurance that these efforts will lead to successful market entry or profitability.
- Market Volatility and Share Price [medium — market]: The common stock is trading at a low price of $0.2262 per share as of December 8, 2025. This low valuation indicates significant market skepticism and potential volatility, impacting the company's ability to raise capital through equity offerings.
- Dependence on Future Acquisitions and Partnerships [medium — operational]: The company's strategic outlook includes potential future acquisitions, partnerships, and international expansion. The success of these ventures, including potential deals with Lyocon S.r.l., Orbit S.r.l., and Tekne S.p.A., is uncertain and carries inherent risks.
- Maintaining NYSE American Listing [medium — regulatory]: A key strategic outlook for the company is maintaining its listing on the NYSE American. Failure to meet listing requirements could result in delisting, significantly impacting liquidity and investor confidence.
Industry Context
Nuburu operates in a highly competitive and rapidly evolving sector, likely related to advanced materials or energy storage given its focus on battery technology. The industry is characterized by significant R&D investment, the need for rapid commercialization, and intense competition from established players and emerging startups. Success hinges on technological innovation, cost-effective production, and securing strategic partnerships.
Regulatory Implications
The S-1 filing itself is a significant regulatory event, enabling the resale of shares and potential future equity raises. Companies in this sector must also navigate evolving environmental, safety, and manufacturing regulations. Maintaining compliance with exchange listing requirements (NYSE American) is critical for continued access to public markets.
What Investors Should Do
- Monitor SEPA utilization
- Assess commercialization progress
- Evaluate strategic partnerships
- Track NYSE American listing status
Key Dates
- 2025-05-30: Standby Equity Purchase Agreement (SEPA) executed — Establishes a framework for potential future capital raises of up to $28.5 million from YA II PN, LTD.
- 2025-12-08: Common Stock last quoted sale price — Indicates a low trading price of $0.2262 per share, reflecting current market sentiment.
- 2025-12-12: S-1 Registration Statement filing date — Initiates the process for the Selling Stockholder to offer up to 130 million shares of common stock for resale.
Glossary
- S-1 Registration Statement
- A form filed with the SEC by companies that intend to offer securities to the public. It contains detailed information about the company's business, financial condition, and the securities being offered. (This filing outlines the terms of the potential resale of shares by YA II PN, LTD. and Nuburu's potential equity sales under the SEPA.)
- Selling Stockholder
- An entity that owns shares of a company and intends to sell them to the public through a registration statement. (In this case, YA II PN, LTD. is the Selling Stockholder, offering up to 130 million shares of Nuburu's common stock.)
- Standby Equity Purchase Agreement (SEPA)
- An agreement where a company can sell shares of its stock to an investor at a discount to the market price, typically over a period of time, upon the company's election. (Nuburu has a SEPA with YA II PN, LTD. that could provide up to $28.5 million in gross proceeds if the company chooses to sell shares under this agreement.)
- Emerging Growth Company
- A designation under the JOBS Act for companies with less than $1.235 billion in annual gross revenue, allowing them to benefit from certain exemptions from SEC reporting requirements. (Nuburu's status as an EGC may affect its disclosure obligations and compliance requirements.)
Year-Over-Year Comparison
This S-1 filing does not provide historical financial data for comparison against a previous filing. It primarily focuses on the current registration of shares for resale by a selling stockholder and the terms of a Standby Equity Purchase Agreement. Therefore, a comparison of revenue growth, margin changes, or new risks versus a prior period is not possible based on the information presented here.
Filing Stats: 4,524 words · 18 min read · ~15 pages · Grade level 17.7 · Accepted 2025-12-12 17:11:49
Key Financial Figures
- $0.0001 — Shares") of our common stock, par value $0.0001 per share ("Common Stock"). The share
- $28.5 million — ckholder. However, we may receive up to $28.5 million aggregate gross proceeds, based on the
- $0.2262 — ck as reported on the NYSE American was $0.2262 per share. We have not listed, nor do w
- $0.01 — to Anzu Partners with a strike price of $0.01 per share for 500,000 shares of Preferr
- $100 million — o sell to the Selling Stockholder up to $100 million of its shares of Common Stock (the "Com
Filing Documents
- buru-20251212.htm (S-1) — 9622KB
- buru-ex5_1.htm (EX-5.1) — 27KB
- buru-ex23_1.htm (EX-23.1) — 5KB
- buru-exfiling_fees.htm (EX-FILING FEES) — 25KB
- img90740621_0.jpg (GRAPHIC) — 12KB
- img208656848_0.jpg (GRAPHIC) — 23KB
- 0001193125-25-317753.txt ( ) — 38538KB
- buru-20251212.xsd (EX-101.SCH) — 3988KB
- buru-20251212_htm.xml (XML) — 8155KB
- buru-exfiling_fees_htm.xml (XML) — 5KB
Risk Factors
Risk Factors 9 The Standby Equity Purchase Agreement 27
Use of Proceeds
Use of Proceeds 32 Determination of Offering Price 32 Market for Common Stock and Dividend Policy 32 Our Business 32
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 41 Selling Stockholder 61
Description of Securities to Be Registered
Description of Securities to Be Registered 62
Legal Proceedings
Legal Proceedings 65 Executive Officers, Directors and Director Independence 65
Executive Compensation
Executive Compensation 68 Director Compensation 71
Security Ownership of Certain Beneficial Owners and Management
Security Ownership of Certain Beneficial Owners and Management 73 Certain Relationships and Related Party Transactions 75 Plan of Distribution 84 Legal Matters 85 Experts 86 Where You Can Find More Information 86 Incorporation of Certain Information by Reference 86 Index to Financial Statements F- 1 i Table of Contents About T his Prospectus This prospectus is part of a registration statement on Form S-1 that we filed with the U.S. Securities and Exchange Commission (the "SEC"). Under this registration process, the Selling Stockholder may, from time to time, sell the securities described in this prospectus. We will not receive any proceeds from the sale by the Selling Stockholder of the securities offered in this prospectus. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part that may contain material information relating to this offering. The prospectus supplement or post-effective amendment may also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. Before purchasing any securities, you should carefully read this prospectus, any post-effective amendment, and any applicable prospectus supplement, together with the additional information described under the headings " Where You Can Find More Information ". Neither we nor the Selling Stockholder have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any post-effective amendment, or any applicable prospectus supplement prepared by or on behalf of us or to which we have referred you. We and the Selling Stockholder take no responsibility for and can provide no assurance as t